Video Experimental Relacionado
Updated: Jul 19, 2026
19:02
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Published on: March 22, 2011
El reclutamiento de la metiltransferasa y la hipermetilación del ADN de los promotores objetivo por un factor de
Luciano Di Croce1, Veronica A Raker, Massimo Corsaro
1Department of Experimental Oncology, European Institute of Oncology, Milan, Italy. ldicroce@lar.ieo.it
Science (New York, N.Y.)
|February 9, 2002
Resumen
La proteína de fusión PML-RAR causa el silenciamiento de genes a través de la hipermetilación del ADN, lo que conduce a la leucemia. El ácido retinoico invierte esto, destacando los cambios epigenéticos en el desarrollo del cáncer.
Área de la Ciencia:
- Biología molecular La biología molecular.
- Investigación del cáncer investigación del cáncer.
- La epigenética es la epigenética.
Sus antecedentes:
- La metilación del ADN es un mecanismo clave para silenciar los genes supresores de tumores en el cáncer.
- Los mecanismos moleculares precisos que dictan la especificidad de la metilación del ADN siguen siendo en gran medida desconocidos.
- Los patrones aberrantes de metilación del ADN son las características de la transformación maligna.
Objetivo del estudio:
- Aclarar los mecanismos moleculares por los cuales la proteína de fusión PML-RAR induce la hipermetilación y el silenciamiento de genes.
- Para investigar el papel de la hipermetilación mediada por PML-RAR en la leucemogénesis.
- Para determinar si el objetivo de la desmetilación del ADN puede revertir el fenotipo transformado.
Principales métodos:
- Investigó el reclutamiento de las ADN metiltransferasas (DNMT) para atacar a los promotores de genes por la proteína de fusión PML-RAR.
- Se evaluó el impacto de la hipermetilación inducida por PML-RAR en la expresión génica y la transformación celular.
- Utilizado el tratamiento con ácido retinoico para inducir la desmetilación del promotor y observar la reversión fenotípica.
Principales resultados:
- La proteína de fusión PML-RAR recluta activamente metiltransferasas de ADN a promotores de genes específicos, lo que lleva a la hipermetilación de genes y el silenciamiento transcripcional.
- Se encontró que esta hipermetilación inducida por PML-RAR contribuye significativamente al potencial leucemogénico de la proteína.
- El tratamiento con ácido retinoico resultó en la desmetilación del promotor, la restauración de la expresión génica y la reversión del fenotipo celular transformado.
Conclusiones:
- Estableció un vínculo mecánico directo entre las alteraciones genéticas (fusión PML-RAR) y los cambios epigenéticos (hipermetilación del ADN) en el desarrollo del cáncer.
- Se demostró que la hipermetilación del ADN inducida por PML-RAR es un factor crítico en las primeras etapas de la carcinogénesis.
- Mostró el ácido retinoico como un agente terapéutico potencial capaz de revertir las modificaciones epigenéticas oncogénicas.
Más Videos Relacionados
Videos de Conceptos Relacionados
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...